A biodegradable porous particle for the controlled biofactor delivery which assembly of pores in scaffolds can improve the permeation and diffusion of drugs or growth factors.
Objective:
Porous-spheres in millimeter scale were prepared by mixing sodium alginate and gelatin interpenetrating networks with cross-linkers; interconnected open pores were fabricated through solvent casting and particulate leaching.
Methods:
Morphological characteristics, degradation, and bovine serum albumin (BSA) release rates of the porous-spheres immersed in three different solutions, namely, deionized distilled water, simulated body fluid (SBF), and phosphate-buffered saline (PBS), were detected.
Results:
Porous-spheres with a large amount of gelatin exhibited an increase in water absorption rates without affecting scaffold strength and no cytotoxicity was elicited. Highly interconnected pores with a diameter of 100–200 µm were uniformly distributed in scaffolds. The weight loss in PBS was faster than that in other solutions; the highest release rate of BSA in SBF was observed for 2 h. The release rates also exhibited linear patterns from 2 h to 24 h in all of the groups.
Conclusions:
After 1 d of immersion in solutions, BSA release rates in scaffolds logarithmically decreased for 14 d. The degradation of porous-spheres also showed an inverse pattern.
LiR.H.WhiteM.WilliamsS. and HazlettT., Poly(vinyl alcohol) synthetic polymer foams as scaffolds for cell encapsulation, J Biomater Sci Polym Ed9 (1998), 239–258. doi:10.1163/156856298X00631.
2.
SongK.LiuY.MacedoH.M.JiangL.LiC.MeiG. and LiuT., Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres, Mater Sci Eng C Mater Biol Appl33 (2013), 1506–1513. doi:10.1016/j.msec.2012.12.054.
3.
JinY.C.KimS.W.ChengF.ShinJ.H.ParkJ.K.LeeS.et al., The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain, Biomaterials32 (2010), 899–908. doi:10.1016/j.biomaterials.2010.09.054.
4.
NotodihardjoP.V.MorimotoN.KakudoN.MatsuiM.SakamotoM.LiemP.H.et al., Gelatin hydrogel impregnated with platelet-rich plasma releasate promotes angiogenesis and wound healing in murine model, J Artif Organs18 (2015), 64–71. doi:10.1007/s10047-014-0795-8.
5.
KangM.L.ChoC.S. and YooH.S., Application of chitosan microspheres for nasal delivery of vaccines, Biotechnol Adv27 (2009), 857–865. doi:10.1016/j.biotechadv.2009.06.007.
6.
SinhV.R. and TrehanA., Biodegradable microspheres for protein delivery, J Control Release90 (2003), 261–280. doi:10.1016/S0168-3659(03)00194-9.
7.
MandalB.B. and KunduS.C., Calcium alginate beads embedded in silk fibroin as 3D dual drug releasing scaffolds, Biomaterials30 (2009), 5170–5177. doi:10.1016/j.biomaterials.2009.05.072.
8.
TanH.WuJ.LaoL. and GaoC., Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering, Acta Biomater5 (2009), 328–337. doi:10.1016/j.actbio.2008.07.030.
9.
ThuH.E. and NgS.F., Gelatine enhances drug dispersion in alginate bilayer film via the formation of crystalline microaggregates, Int J Pharm454 (2013), 99–106. doi:10.1016/j.ijpharm.2013.06.082.
10.
GombotzW.R. and WeeS., Protein release from alginate matrices, Adv Drug Deliv Rev31 (1998), 267–285. doi:10.1016/S0169-409X(97)00124-5.
11.
AugstA.D.KongH.J. and MooneyD.J., Alginate hydrogels as biomaterials, Macromol Biosci6 (2006), 623–633. doi:10.1002/mabi.200600069.
12.
AlmeidaP.F. and AlmeidaA.J., Cross-linked alginate-gelatine beads: A new matrix for controlled release of pindolol, J Control Release97 (2004), 431–439. doi:10.1016/j.jconrel.2004.03.015.
13.
LeeK.Y. and MooneyD.J., Hydrogels for tissue engineering, Chem Rev101 (2001), 1869–1879. doi:10.1021/cr000108x.
14.
LuA.ZhuJ.ZhangG. and SunG., Gelatin nanofibers fabricated by extruding immiscible polymer solution blend and their application in tissue engineering, J Mater Chem21 (2011), 18674–18680. doi:10.1039/c1jm13059e.
15.
BertoldoM.BroncoS.GragnoliT. and CiardelliF., Modification of gelatin by reaction with 1,6-diisocyanatohexane. Macromol Biosci7 (2007), 328–338. doi:10.1002/mabi.200600215.
16.
SarikaP.R.CinthyaK.JayakrishnanA.AnilkumarP.R. and JamesN.R., Modified gum Arabic cross-linked gelatin scaffold for biomedical applications, Mater Sci Eng C Mater Biol Appl43 (2014), 272–279. doi:10.1016/j.msec.2014.06.042.
17.
BigiA.CojazzibG.PanzavoltaaS.RoveriaN. and RubiniK., Stabilization of gelatin films by crosslinking with genipin, Biomaterials23 (2002), 4827–4832. doi:10.1016/S0142-9612(02)00235-1.
18.
MikosA.G.SarakinosG.LeiteS.M.VacantiJ.P. and LangerR., Laminated three-dimensional biodegradable foams for use in tissue engineering, Biomaterials14 (1993), 323–330. doi:10.1016/0142-9612(93)90049-8.
19.
KoC.L.TienY.C.WangJ.C. and ChenW.C., Characterization of controlled highly porous hyaluronan/gelatin cross-linking sponges for tissue engineering, J Mech Behav Biomed Mater14 (2012), 227–238. doi:10.1016/j.jmbbm.2012.06.019.
20.
MizutaniN.KageyamaS.YamadaM.HasegawaM.MiyamotoK. and HoriuchiT., The behavior of ligament cells cultured on elastin and collagen scaffolds, J Artif Organs17 (2014), 50–59. doi:10.1007/s10047-013-0736-y.
21.
XiaoC.LiH. and GaoY., Preparation of fast pH responsive ferric carboxymethylcellulose/poly (vinyl alcohol) double network microparticles, Polym Int58 (2009), 112–115. doi:10.1002/pi.2502.
22.
QiuY. and ParkK., Environment-sensitive hydrogels for drug delivery, Adv Drug Deliv Rev53 (2001), 321–339. doi:10.1016/S0169-409X(01)00203-4.
23.
XingL.DaweiC.LipingX. and RongqingZ., Oral colon-specific drug delivery for bee venom peptide: Development of a coated calcium alginate gel beads-entrapped liposome, J Controlled Release93 (2003), 293–300. doi:10.1016/j.jconrel.2003.08.019.
24.
MartinsS.SarmentoB.SoutoE.B. and FerreiraD.C., Insulin-loaded alginate microspheres for oral delivery-effect of polysaccharide reinforcement on physicochemical properties and release profile, Carbohydr Polym69 (2007), 725–731. doi:10.1016/j.carbpol.2007.02.012.
25.
HuangX.XiaoY. and LangM., Micelles/sodium-alginate composite gel beads: A new matrix for oral drug delivery of indomethacin, Carbohydr Polym87 (2012), 790–798. doi:10.1016/j.carbpol.2011.08.067.
26.
GeorgeM. and AbrahamT.E., pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs, Int J Pharm335 (2007), 123–129. doi:10.1016/j.ijpharm.2006.11.009.
27.
DongZ.WangQ. and DuY., Alginate/gelatin blend films and their properties for drug controlled release, J Membr Sci280 (2006), 37–44. doi:10.1016/j.memsci.2006.01.002.
28.
XiaoC.B.LiuH.J.LuY.S. and ZhangL.N., Blend films from sodium alginate and gelatin solutions, J Macromol Sci A Pure Appl Chem38 (2001), 317–328. doi:10.1081/MA-100103352.
29.
WangQ.HuX.DuY. and KennedyJ.F., Alginate/starch blend fibers and their properties for drug controlled release, Carbohydr Polym82 (2010), 842–847. doi:10.1016/j.carbpol.2010.06.004.
30.
ChanL.W.JinY. and HengP.W.S., Cross-linking mechanisms of calcium and zinc in production of alginate microspheres, Int J Pharm242 (2002), 255–258. doi:10.1016/S0378-5173(02)00169-2.
31.
PerezR.A.KimM.KimT.H.KimJ.H.LeeJ.H.ParkJ.H.et al., Utilizing core-shell fibrous collagen-alginate hydrogel cell delivery system for bone tissue engineering, Tissue Eng A20 (2014), 103–114. doi:10.1089/ten.tea.2013.0198.
32.
PanouilléM. and Larreta-GardeV., Gelation behaviour of gelatin and alginate mixtures, Food Hydrocoll23 (2009), 1074–1080. doi:10.1016/j.foodhyd.2008.06.011.
33.
BajpaiS.K. and SharmaS., Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions, React Funct Polym59 (2004), 129–140. doi:10.1016/j.reactfunctpolym.2004.01.002.
34.
HoffmanA.S., Hydrogels for biomedical applications, Adv Drug Deliv Rev43 (2002), 3–12. doi:10.1016/S0169-409X(01)00239-3.
35.
PasparakisG. and BouropoulosN., Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads, Int J Pharm323 (2006), 34–42. doi:10.1016/j.ijpharm.2006.05.054.
